A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease

Clinical trial NCT06818838 · RECRUITING

Trial details

NCT number: NCT06818838
Sponsor: Lingyi Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gaucher Disease Type 1

Start date: 2024-07-05
Primary completion: 2027-07-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.